Carlos D'APparecida Santos Machado Filho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carlos D'APparecida Santos Machado Filho has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Paulo Ricardo Criado
Centro Universitário Faculdade de Medicina do ABC, Santo André, SP, Brazil; Faculdade de Ciências Médicas de Santos (Fundação Lusíada), Santos, SP, Brazil
9 shared publications - Francisco Macedo Paschoal
Faculdade de Medicina do ABC
4 shared publications - Roberta Fachini Jardim Criado
Centro Universitário Faculdade de Medicina do ABC, Santo André, SP, Brazil; Alergoskin Alergia e Dermatologia, UCARE Center and ADCARE, Santo André, SP, Brazil
4 shared publications - Maria Aparecida Silva Pinhal
Department of Biochemistry, FMABC University Center, Santo André, SP, 09060-650, Brazil
3 shared publications - Ana Maria Giménez Arnau
Department of Dermatology Hospital del Mar Research Institute Barcelona Spain
2 shared publications - Beatriz Alessi Rodrigues de Espindola
Department of Dermatology, Faculdade de Medicina do ABC, Santo André, SP, Brazil
2 shared publications
Latest Publications
- Open Access
- 18 January 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 98 (2) , 236-239
Prevalence of filaggrin gene polymorphisms (exon-3) in patients with atopic dermatitis in a multiracial Brazilian population
- 18 January 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 98 (2) , 236-239
Open AccessPrevalence of filaggrin gene polymorphisms (exon-3) in patients with atopic dermatitis in a multiracial Brazilian population
- Open Access
- 1 July 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (4) , 436-441
Quais lições podemos aprender? Análise epidemiológica de 267 pacientes com urticária em centro terciário brasileiro
- 1 July 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (4) , 436-441
Open AccessQuais lições podemos aprender? Análise epidemiológica de 267 pacientes com urticária em centro terciário brasileiro
- Open Access
- 1 July 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (4) , 436-441
What lessons can we learn? Clinical and epidemiological retrospective analysis of 267 patients with urticaria in a Brazilian tertiary center
- 1 July 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (4) , 436-441
Open AccessWhat lessons can we learn? Clinical and epidemiological retrospective analysis of 267 patients with urticaria in a Brazilian tertiary center
- Open Access
- 1 March 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (2) , 148-154
Avaliação dos níveis séricos de proteína C‐reativa, D‐dímero e do teste do soro autólogo em pacientes com urticária crônica espontânea em um centro terciário brasileiro: estudo transversal
- 1 March 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (2) , 148-154
Open AccessAvaliação dos níveis séricos de proteína C‐reativa, D‐dímero e do teste do soro autólogo em pacientes com urticária crônica espontânea em um centro terciário brasileiro: estudo transversal
- Open Access
- 1 March 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (2) , 148-154
Evaluation of serum levels of C-reactive protein, D-Dimer and Autologous Serum Skin Test in patients with Chronic Spontaneous Urticaria in a Brazilian tertiary center : a cross-sectional study
- 1 March 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (2) , 148-154
Open AccessEvaluation of serum levels of C-reactive protein, D-Dimer and Autologous Serum Skin Test in patients with Chronic Spontaneous Urticaria in a Brazilian tertiary center : a cross-sectional study
- Open Access
- 1 November 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 95 (6) , 714-720
Menos é mais: estudo das diferentes formas de fechamento de feridas operatórias após cirurgia micrográfica de Mohs
- 1 November 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 95 (6) , 714-720
Open AccessMenos é mais: estudo das diferentes formas de fechamento de feridas operatórias após cirurgia micrográfica de Mohs
- Open Access
- 1 November 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 95 (6) , 714-720
Keep it simple. A ten-year experience in reconstructions after Mohs micrographic surgery
- 1 November 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 95 (6) , 714-720
Open AccessKeep it simple. A ten-year experience in reconstructions after Mohs micrographic surgery
- Open Access
- 1 September 2020
- Published by FapUNIFESP (SciELO) in Revista Bioética
- Vol. 28 (3) , 517-521
Termo de consentimento informado: impacto na decisão judicial
Art. 6º São direitos básicos do consumidor:
- 1 September 2020
- Published by FapUNIFESP (SciELO) in Revista Bioética
- Vol. 28 (3) , 517-521
Open AccessTermo de consentimento informado: impacto na decisão judicial
Art. 6º São direitos básicos do consumidor:
- 20 April 2020
- Published by Wiley in International Journal of Dermatology
- Vol. 59 (6) , 722-725
Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree
Background: Erythrokeratodermas are a heterogeneous group of keratinization disorders. They are inherited in both autosomal dominant and autosomal recessive pattern. Erythrokeratoderma variabilis et progressive (EKVP) is a disorder caused by variations in genes that codify connexins (GJA1, GJB3, GJB4). The distinction between different phenotypes is not always simple. Age of presentation varies from birth to adulthood; stationary or migratory erythematous plaques associated with nonmigratory hyperkeratosis are characteristic of this disorder. Nails, hair, and teeth are not affected.Methods: In order to describe the clinical phenotypes and molecular findings in a large Brazilian pedigree affected by erythrokeratoderma, we performed a clinical evaluation of four patients with different presentations of erythrokeratoderma from the same family, in which there are 35 affected members distributed in six generations. Genomic DNA evaluation by Sanger sequencing of GJB3 and GJB4 was performed in two affected family members with different phenotypes.Results: Clinical heterogeneity in affected patients was remarkable. In patients investigated with genetic testing, a heterozygous pathogenic gene variant in the GJB4 (gap junction protein beta‐4) gene was found positive for GJB4:c.35G>A (rsrs80358211). One patient also presented a synonymous variant in GJB3:c.357C>T (rs41310442).Conclusion: Variants in GJB4 are classically associated with Erythrokeratodermia variabilis, but there is remarkable clinical heterogeneity. Our observation that the same variant caused different phenotypes within the same family corroborates clinical heterogeneity and suggests that other genes that compose the genetic background exert some influence on the disease phenotype.
- 20 April 2020
- Published by Wiley in International Journal of Dermatology
- Vol. 59 (6) , 722-725
Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree
Background: Erythrokeratodermas are a heterogeneous group of keratinization disorders. They are inherited in both autosomal dominant and autosomal recessive pattern. Erythrokeratoderma variabilis et progressive (EKVP) is a disorder caused by variations in genes that codify connexins (GJA1, GJB3, GJB4). The distinction between different phenotypes is not always simple. Age of presentation varies from birth to adulthood; stationary or migratory erythematous plaques associated with nonmigratory hyperkeratosis are characteristic of this disorder. Nails, hair, and teeth are not affected.Methods: In order to describe the clinical phenotypes and molecular findings in a large Brazilian pedigree affected by erythrokeratoderma, we performed a clinical evaluation of four patients with different presentations of erythrokeratoderma from the same family, in which there are 35 affected members distributed in six generations. Genomic DNA evaluation by Sanger sequencing of GJB3 and GJB4 was performed in two affected family members with different phenotypes.Results: Clinical heterogeneity in affected patients was remarkable. In patients investigated with genetic testing, a heterozygous pathogenic gene variant in the GJB4 (gap junction protein beta‐4) gene was found positive for GJB4:c.35G>A (rsrs80358211). One patient also presented a synonymous variant in GJB3:c.357C>T (rs41310442).Conclusion: Variants in GJB4 are classically associated with Erythrokeratodermia variabilis, but there is remarkable clinical heterogeneity. Our observation that the same variant caused different phenotypes within the same family corroborates clinical heterogeneity and suggests that other genes that compose the genetic background exert some influence on the disease phenotype.
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (1) , 36-41
Dosages of androgenic hormones in adolescent patients with severe acne
SUMMARY OBJECTIVE Acne vulgaris in female adolescents, when severe or accompanied by other signs of androgenization, may represent a sign of hyperandrogenemia often underdiagnosed, which will have harmful consequences for adult life. The objective of this cross-sectional and retrospective study was to demonstrate the incidence of hormonal changes in the cases of female adolescents with severe or extensive acne, with or without other signs of hyperandrogenism, and propose a hormonal research pattern which should be indicated in order to detect early hyperandrogenemia. METHODS The medical records of 38 female patients aged between 9 and 15 years old with grade II and/or III acne were analyzed. The dehydroepiandrosterone sulfate, dehydroepiandrostenedione, and androstenedione, total testosterone, and dihydrotestosterone sulfate hormones were required prior to initiation of treatment. The hormonal dosages were performed in the serum after at least 3 hours of fasting by means of radioimmunoassay tests. RESULTS Of the 38 patients included, 44.7% presented changes in androgen levels (hyperandrogenemia), and the two most frequently altered hormones were DHEA and androstenedione, with the same incidence (23.6%). CONCLUSIONS The correct and early diagnosis provides an effective and agile approach, including antiandrogen therapy, with the purpose of avoiding the reproductive and metabolic repercussions, besides controlling the inflammatory picture and avoid aesthetic complications.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (1) , 36-41
Open AccessDosages of androgenic hormones in adolescent patients with severe acne
SUMMARY OBJECTIVE Acne vulgaris in female adolescents, when severe or accompanied by other signs of androgenization, may represent a sign of hyperandrogenemia often underdiagnosed, which will have harmful consequences for adult life. The objective of this cross-sectional and retrospective study was to demonstrate the incidence of hormonal changes in the cases of female adolescents with severe or extensive acne, with or without other signs of hyperandrogenism, and propose a hormonal research pattern which should be indicated in order to detect early hyperandrogenemia. METHODS The medical records of 38 female patients aged between 9 and 15 years old with grade II and/or III acne were analyzed. The dehydroepiandrosterone sulfate, dehydroepiandrostenedione, and androstenedione, total testosterone, and dihydrotestosterone sulfate hormones were required prior to initiation of treatment. The hormonal dosages were performed in the serum after at least 3 hours of fasting by means of radioimmunoassay tests. RESULTS Of the 38 patients included, 44.7% presented changes in androgen levels (hyperandrogenemia), and the two most frequently altered hormones were DHEA and androstenedione, with the same incidence (23.6%). CONCLUSIONS The correct and early diagnosis provides an effective and agile approach, including antiandrogen therapy, with the purpose of avoiding the reproductive and metabolic repercussions, besides controlling the inflammatory picture and avoid aesthetic complications.